Latest evidence-based view

ROM · BUY

ROM: the available evidence currently favors buying. 1 month +15.70% · 3 months +20.62% · 1 year +78.36%.

SELLOriginal source alertBUYEvidence-reviewed stance240Alert timeframe

ROM: the available evidence currently favors buying.

1 month +15.70% · 3 months +20.62% · 1 year +78.36%. Taken together, the verified indicators provide stronger positive evidence.

Weaker indicators could change the assessment, but the current balance of evidence favors buying.

Buy in stages rather than all at once, and review your position if the three-month trend weakens.

Market evidence

169.25Reference price

15.71-month return

20.623-month return

78.361-year return

98.252-week range position

2026-10-06T13:30:00+00:00Market data as of

Instrument profile

ProShares Ultra Technology

DescriptionProShares Ultra TechnologySecurity TypefundSecurity SubtypeetfSectorMiscellaneousIndustryInvestment Trusts/Mutual FundsBeta 1Y3.42Expense Ratio Percent0.93Nav167.4654

Referenced public sources

No article citation was required for this evidence review.